Higher pre-diagnosis OPG concentrations were associated with an increased risk of breast cancer-specific mortality among women with ER+ disease (quintile (q)5 vs. q1 HR 1.77 [CI 1.03, 3.04]; ptrend 0.10) (Table 2). This evidence concerns the gene TNFRSF11B and breast cancer.